VEGFA and neoplasm: Dopamine, by occupying the D2 receptors, can inhibit angiogenesis, preventing the phosphorylation of VEGFR-2 from endothelial cells in tumor tissue and blocking the effect of VEGF, generating an antiangiogenic effect [112].